Plasma tumor necrosis factor soluble receptors in chronic renal failure.
Two soluble tumor necrosis factor receptors (sTNFRs) were detected in the plasma of patients with different degrees of chronic renal failure (CRF) and of long-term hemodialysis (HD) patients. In uremic undialyzed patients, plasma levels of both sTNFRs increased progressively with declining renal function. A linear correlation was found between sTNFR plasma levels and plasma creatinine concentration. sTNFR levels in end-stage uremic patients shortly before commencement of first HD treatment were approximately tenfold higher than in normal subjects. Long-term HD patients showed a further increase in plasma sTNFRs. The origin of sTNFRs, as well as their physiological role remains to be elucidated.
Brockhaus
M
M
Central Research Units F., Hoffmann-La Roche Ltd., Basel, Switzerland.
Bar-Khayim
Y
Y
Gurwicz
S
S
Frensdorff
A
A
Haran
N
N
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007118:Immunoassay; D007668:Kidney / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D011956:Receptors, Cell Surface / Q000378:metabolism*; D018124:Receptors, Tumor Necrosis Factor; D006435:Renal Dialysis; D012995:Solubility; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D011956:Receptors, Cell Surface; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha